SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-034615
Filing Date
2023-07-14
Accepted
2023-07-14 16:30:35
Documents
12
Period of Report
2023-07-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K brhc20055895_8k.htm   iXBRL 8-K 36718
  Complete submission text file 0001140361-23-034615.txt   173743

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA infi-20230714.xsd EX-101.SCH 3853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE infi-20230714_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE infi-20230714_pre.xml EX-101.PRE 16036
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc20055895_8k_htm.xml XML 4241
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 231089443
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences